Similarly, increased TBK1 expression and/or aberrant TBK1 activity have been reported in many types of cancers, such as breast cancer [71], which may be due to the high expression of TBK1 promoting viability, proliferation, migration, and invasion of cancer cells through activation of the mTOR signaling pathway [72]. This evidence concerns the gene MTOR and breast cancer.